beta-Catenin mutations in cell lines established from human colorectal cancers

被引:435
|
作者
Ilyas, M
Tomlinson, IPM
Rowan, A
Pignatelli, M
Bodmer, WF
机构
[1] ROYAL MARSDEN HOSP, CANC RES INST, HADDOW LABS, SUTTON SH2 5NG, SURREY, ENGLAND
[2] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT PATHOL, LONDON W12 0HS, ENGLAND
关键词
sequencing; CTNNB1; intestinal cancer;
D O I
10.1073/pnas.94.19.10330
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
beta-catenin has functions as both an adhesion and a signaling molecule, Disruption of these functions through mutations of the beta-catenin gene (CTNNB1) may be important in the development of colorectal tumors, We examined the entire coding sequence of beta-catenin by reverse transcriptase-PCR (RT-PCR) and direct sequencing of 23 human colorectal cancer cell lines from 21 patients, In two cell lines, there was apparent instability of the beta-catenin mRNA. Five different mutations (26%) were found in the remaining 21cell lines (from 19 patients), A three-base deletion (codon 45) was identified in the cell line HCT 116, whereas cell lines SW 48, HCA 46, CACO 2, and Cole 201 each contained single-base missense mutations (codons 33, 183, 245, and 287, respectively), All 23 cell lines had full-length beta-catenin protein that was detectable by Western blotting and that coprecipitated with E-cadherin, In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable. In SW48 and HCA 46, however, we did not detect complexes of beta-catenin protein with alpha-catenin and APC, respectively, These results show that selection of CTNNB1 mutations occurs in up to 26% of colorectal cancers from which cell lines are derived. In these cases, mutation selection is probably for altered beta-catenin function, which may significantly alter intracellular signaling and intercellular adhesion and may serve as a complement to APC mutations in the early stages of tumorigenesis.
引用
收藏
页码:10330 / 10334
页数:5
相关论文
共 50 条
  • [1] The low frequency of beta-catenin mutations in cell lines established from human colorectal cancers
    Ilyas, M
    Tomlinson, IPM
    Rowan, A
    Pignatelli, M
    Bodmer, WF
    JOURNAL OF PATHOLOGY, 1997, 181 : A36 - A36
  • [2] beta-Catenin expression in human cancers
    Takayama, T
    Shiozaki, H
    Shibamoto, S
    Oka, H
    Kimura, Y
    Tamura, S
    Inoue, M
    Monden, T
    Ito, F
    Monden, M
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 148 (01): : 39 - 46
  • [3] The role of the oncoprotein beta-catenin in the progression of colorectal cancers
    Brabletz, T
    VERHANDLUNGEN DER DEUTSCHEN GESELLSCHAFT FUR PATHOLOGIE 85. TAGUNG: PATHOLOGIE FUR DAS 21. JAHRHUNDERT, 2001, 85 : 243 - 249
  • [4] beta-catenin expression in human cancers.
    Takayama, T
    Shiozaki, H
    Tamura, S
    Inoue, M
    Monden, M
    GASTROENTEROLOGY, 1996, 110 (04) : A600 - A600
  • [5] Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma
    Iwai, S
    Katagiri, W
    Kong, C
    Amekawa, S
    Nakazawa, M
    Yura, Y
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (12) : 773 - 782
  • [6] Stabilization of beta-catenin by genetic defects in melanoma cell lines
    Rubinfeld, B
    Robbins, P
    ElGamil, M
    Albert, I
    Porfiri, E
    Polakis, P
    SCIENCE, 1997, 275 (5307) : 1790 - 1792
  • [7] Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma
    Soichi Iwai
    Wataru Katagiri
    Chie Kong
    Shigeki Amekawa
    Mitsuhiro Nakazawa
    Yoshiaki Yura
    Journal of Cancer Research and Clinical Oncology, 2005, 131 : 773 - 782
  • [8] ANTICANCER HORMONES MADE IN THE HEART TARGET BETA-CATENIN IN HUMAN CANCERS
    Vesely, D. L.
    Skelton, W. P.
    Skelton, M. N.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (02) : 503 - 503
  • [9] Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)
    Tejpar, S
    Nollet, F
    Li, C
    Wunder, JS
    Michils, G
    dal Cin, P
    Van Cutsem, E
    Bapat, B
    van Roy, F
    Cassiman, JJ
    Alman, BA
    ONCOGENE, 1999, 18 (47) : 6615 - 6620
  • [10] Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)
    Sabine Tejpar
    Friedel Nollet
    Catherine Li
    Jay S Wunder
    Genevieve Michils
    Paola dal Cin
    Eric Van Cutsem
    Bharati Bapat
    Frans van Roy
    Jean Jacques Cassiman
    Benjamin A Alman
    Oncogene, 1999, 18 : 6615 - 6620